This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Abstract Details

Activity Number: 128
Type: Contributed
Date/Time: Monday, August 2, 2010 : 8:30 AM to 10:20 AM
Sponsor: Biopharmaceutical Section
Abstract - #309378
Title: A Bayesian Modeling Approach for Safety Data Analysis in Drug Development
Author(s): Yu Gu*+ and Ke Zhang and Liqiang Yang
Companies: Florida State University and Pfizer Inc. and Pfizer Inc.
Address: 214 OSB 117 N. Woodward, Tallahassee, FL, 32306,

Safety planning and evaluation becomes a primary focus in drug development and occurs throughout a product's life-cycle. The use of modeling-based quantitative approaches plays an important role in the identification of potential safety issues and the assessment of the relation between important factors and safety response. We propose a Bayesian logistic mixed effect model to analyze AE data. System organ class is also considered in the model; therefore, the information within the same system organ class can be borrowed to help model the rate of AEs. The multiplicity issue in AE data analysis is easily solved by the Bayesian framework. In addition, the additional important risk factors can be easily added in the model. The Bayesian posterior predictive information can also help study teams do safety planning for the late-phase drug development.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2010 program

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.